312 related articles for article (PubMed ID: 29683112)
1. A Panel of Serum Noncoding RNAs for the Diagnosis and Monitoring of Response to Therapy in Patients with Breast Cancer.
Huang SK; Luo Q; Peng H; Li J; Zhao M; Wang J; Gu YY; Li Y; Yuan P; Zhao GH; Huang CZ
Med Sci Monit; 2018 Apr; 24():2476-2488. PubMed ID: 29683112
[TBL] [Abstract][Full Text] [Related]
2. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs as circulating biomarkers in osteosarcoma patients.
Botti G; Giordano A; Feroce F; De Chiara AR; Cantile M
J Cell Physiol; 2019 Nov; 234(11):19249-19255. PubMed ID: 31032924
[TBL] [Abstract][Full Text] [Related]
4. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
5. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
7. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
8. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
9. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of let-7a-5p and miR-21-5p in Patients with Breast Cancer.
Chen C; Liu X; Chen C; Chen Q; Dong Y; Hou B
Ann Clin Lab Sci; 2019 May; 49(3):302-308. PubMed ID: 31308028
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
12. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
Viereck J; Thum T
Circ Res; 2017 Jan; 120(2):381-399. PubMed ID: 28104771
[TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer.
Zidan HE; Karam RA; El-Seifi OS; Abd Elrahman TM
Cancer Genet; 2018 Jan; 220():32-37. PubMed ID: 29310836
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
16. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
17. The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer.
Zhao L; Zhao Y; He Y; Li Q; Mao Y
Cell Signal; 2018 Nov; 51():152-165. PubMed ID: 30092355
[TBL] [Abstract][Full Text] [Related]
18. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
[TBL] [Abstract][Full Text] [Related]
19. Role of noncoding RNAs and untranslated regions in cancer: A review.
Zhang Y; Yang M; Yang S; Hong F
Medicine (Baltimore); 2022 Aug; 101(33):e30045. PubMed ID: 35984196
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.
Schulte C; Barwari T; Joshi A; Theofilatos K; Zampetaki A; Barallobre-Barreiro J; Singh B; Sörensen NA; Neumann JT; Zeller T; Westermann D; Blankenberg S; Marber M; Liebetrau C; Mayr M
Circ Res; 2019 Jul; 125(3):328-340. PubMed ID: 31159652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]